Nicotine and bupropion share a similar discriminative stimulus effect

European Journal of Pharmacology

Volumn 443, Issue 1-3, 2002, Pages 113-118

  Young, Richard ^a   Glennon, Richard A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Depression; Mecamylamine; Smoking; Stimulant

Indexed keywords

AMFEBUTAMONE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION; STIMULUS GENERALIZATION; TASK PERFORMANCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BUPROPION; CENTRAL NERVOUS SYSTEM STIMULANTS; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; GENERALIZATION, STIMULUS; INJECTIONS, SUBCUTANEOUS; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SMOKING CESSATION;

EID: 0037123886     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01554-6     Document Type: Article

References (33)

1. Characterization of the bupropion cue in the rat: Lack of evidence for a dopaminergic mechanism
2. Bupropion: A new treatment for smokers
3. Relationship between bupropion disposition and dopamine uptake inhibition in rats and mice
4. Nicotine and D-amphetamine produce common discriminative stimulus effects in rats
5. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area
6. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
7. Bupropion hydrochloride
8. Safety and efficacy of bupropion, a novel antidepressant
9. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion. HCI - A new atypical antidepressant agent
10. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencylidine and ibogaine
11. Psychoses associated with bupropion treatment
12. Bupropion may not be as good as editorial implies
13. Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine
14. A comparison of sustained-release bupropion and placebo for smoking cessation
15. Stimulus properties of antidepressants in the rat
16. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
17. Nicotine cue in rats: Effects of central administration of ganglion-blocking drugs
18. A comparison of bupropion, dextramphetamine, and placebo in mixed-substance abusers
19. Smoking cessation guidelines for health care professionals
20. Mecamylamine increases nicotine preference and attenuates nicotine discrimination
21. Nicotine as a discriminative stimulus: A neurobiobehavioral approach to studying central cholinergic mechanisms
22. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in D-amphetamine-trained humans
23. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding
24. Metabolism and kinetics of bupropion
25. Antagonism of stimulus properties of nicotine by dihydro-β-erythroidine (DHβE) in rats
26. Bupropion is a nicotinic antagonist
27. Selective antagonism of behavioral effects of nicotine by dihydro-β-erythrodine in rats
28. Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs
29. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats
30. Regulation of dopamine receptors by bupropion: Comparison with antidepressants and CNS stimulants
31. Pharmacological significance of the species differences in bupropion metabolism